Legal Representation
Attorney
F. William McLaughlin
USPTO Deadlines
Next Deadline
1928 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-10-22)
Due Date
October 22, 2030
Grace Period Ends
April 22, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
22 eventsDate | Code | Type | Description |
---|---|---|---|
Apr 12, 2025 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
Mar 26, 2025 | FIMP | P | FINAL DISPOSITION PROCESSED |
Mar 26, 2025 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
Jan 22, 2025 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Oct 22, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Oct 22, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Aug 6, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Aug 6, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
Jul 17, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Jun 27, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jun 20, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Jun 20, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Jun 20, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Jan 23, 2024 | RFNT | P | REFUSAL PROCESSED BY IB |
Dec 28, 2023 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Dec 28, 2023 | RFRR | P | REFUSAL PROCESSED BY MPU |
Dec 20, 2023 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Dec 19, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN |
Dec 19, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
Jun 27, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
Jun 23, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Jun 22, 2023 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 005
Antivirals; antivirals for topical use; Medicine for treatment of infectious diseases, viral infections, herpes simplex virus infections, Medicine for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Medicines for treatment of infectious diseases, viral infections, herpes simplex virus infections for human purposes, Medicines for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections for human purposes; Medicines for treatment of viral infections for veterinary purposes; Medicines for dental purposes; medicated eye lotions for medical use; medicated eye ointment for medical use; Creams for dermatological use; Dermatological-pharmaceutical products; Medicated lip creams; Medicated skin creams; Medicated skin lotions; Medicinal preparations for the treatment of infectious diseases; Medicated ointments for application to the skin for treating dermatological conditions; Medicated preparations for treating dermatological conditions; Medicated ointments for treating dermatological conditions; medicated preparations for the treatment of herpes of the lips; Ophthalmological preparations; Ophthalmic preparations; Ophthalmologic preparations; Pharmaceutical preparations for ophthalmological use; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical products for ophthalmological use; Topical ophthalmic anti-infective substances for the treatment of infections; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical lip ointments; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations and substances for use in gynecology; Pharmaceutical preparations and substances for use in urology; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of diseases of the genitourinary system; Pharmaceutical preparations for the prevention of diseases of the genitourinary system; Pharmaceutical preparations for skin wounds; Sulfonamides being medicines; Sulfonamide preparations; Transdermal patches for medical treatment of infectious diseases, viral infections, herpes simplex virus infections; Pharmaceutical lipsalves; Antiviral drugs for treating herpes simplex virus infections; Preparations for the treatment of genital herpes; Medicinal preparations for the treatment of herpes simplex virus infections; medicinal preparations for the treatment of labial herpes; medicinal preparations for the treatment of mucosal herpes; Pharmaceutical preparations for the treatment of herpes simplex virus infections; Pharmaceutical preparations for skin lesions; Sulfonamides for treatment of infectious diseases, viral infections, herpes simplex virus infections, Sulfonamides for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections, Salts of sulfonamides for treatment of infectious diseases, viral infections, herpes simplex virus infections, Salts of sulfonamides for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Pharmaceutical formulations in the form of tablets for treatment of infectious diseases, viral infections, herpes simplex virus infections, Pharmaceutical formulations in the form of tablets for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Pharmaceutical formulations in the form of solutions for treatment of infectious diseases, viral infections, herpes simplex virus infections, Pharmaceutical formulations in the form of solutions for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Pharmaceutical formulations in the form of suspensions for treatment of infectious diseases, viral infections, herpes simplex virus infections, Pharmaceutical formulations in the form of suspensions for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Pharmaceutical formulations for intra-veneous application for treatment of infectious diseases, viral infections, herpes simplex virus infections, Pharmaceutical formulations for intra-veneous application for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Antiviral drugs for treating of sexually transmittable diseases; Medicinal preparations for the treatment of sexually transmittable diseases.
Class 010
Medical devices for intra-vaginal use for treatment of infectious diseases, viral infections, herpes simplex virus infections; Medical devices for intra-vaginal use for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; medical devices for intra-vaginal application of anti-virals; medical devices for intra-vaginal application of sulfonamides
Class 041
Organization of seminars and conventions in the field of medicine; Publication of scientific information journals; publishing of online electronic publications; publishing of electronic publications; providing education courses in the field of science; Organization of seminars and conventions in the field of virology.
Class 044
Pharmaceutical consultancy services; consultancy and information services relating to medical products; providing health information; information services relating to health care; provision of health information; medical information services provided via the internet
Classification
International Classes
005
010
041
044